A renowned expert in the large scale study of proteins (Proteomics) and tissue imaging mass spectrometry, Professor Peter Hoffmann is the strand leader in Biomaterials Engineering and Nanomedicine at University of South Australia’s Future Industries Institute.
With more than 90 papers published and almost $10 million raised for research, Professor Hoffmann’s area of expertise is focussed on biomarker discovery in cancer, detection of protein phosphorylation and Tissue Imaging Mass Spectrometry.
Professor Hoffmann’s research team were the first to use and publish Imaging Mass Spectrometry (IMS) techniques in Australia, techniques that are used to investigate protein and peptide distributions in human tissue.
More recently Professor Hoffmann formed the spin out company Onco DX to commercialise patented biomarkers for the early detection of ovarian and gastric cancers.
Professor Hoffmann is also Director of the National NCRIS facility for Tissue Imaging Mass Spectrometry.
Project: Ovarian Blood Markers of Ovarian Cancer